Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.20
-0.91 (-4.31%)
At close: Aug 14, 2025, 3:59 PM
20.20
0.00%
Pre-market: Aug 15, 2025, 08:16 AM EDT

Neurogene Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
-925K n/a n/a 925K 925K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.57M 2.39M 2.45M 4.35M 3.92M 3.47M 3.26M 2.01M 12.45M 12.8M 12.85M 12.83M 2.6M 2.43M 2.28M 2.1M 1.95M 2.16M
Gross Profit
-2.37M -2.26M -2.33M -3.42M -2.99M -3.47M -3.26M -2.01M -12.45M -12.8M -12.85M -12.83M -2.6M -2.43M -2.28M -2.1M -1.95M -2.16M
Operating Income
-95.69M -89.75M -82.61M -97.61M -81M -73.46M -66.4M -44.13M -51.56M -54.84M -58.49M -59.41M -61.86M -61.12M -60.7M -58.16M -52.79M -47.43M
Interest Income
10.25M 9.35M 8.47M 6.98M 5.79M 4.49M 2.95M 2.99M 2.79M 2.21M 1.53M 717.5K 271.5K 107.5K 19K 17K 18K 60K
Pretax Income
-84.39M -80.87M -75.14M -71.13M -55.44M -48.81M -46.09M -44.03M -52.06M -55.88M -57.03M -58.75M -61.65M -61.09M -60.69M -58.16M -44.97M -39.59M
Net Income
-84.39M -80.87M -75.14M -71.13M -55.44M -48.81M -46.09M -44.03M -52.06M -55.88M -57.03M -58.75M -61.65M -61.09M -60.69M -58.16M -44.97M -39.59M
Selling & General & Admin
26.93M 25.53M 21.79M 15.63M 14.3M 11.26M 10.26M 13.87M 11.47M 13.39M 13.98M 15.16M 17.95M 18.51M 19.23M 18.84M 17.3M 16.72M
Research & Development
68.76M 65.14M 60.92M 80.19M 64.52M 59.1M 53.25M 28.63M 38.84M 39.47M 42.48M 42.24M 41.31M 40.18M 39.19M 37.21M 33.53M 28.55M
Other Expenses
n/a -817K -817K -819.55K -819.55K -6.55K -9.55K -7K -7K -3K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
95.69M 89.85M 81.89M 95M 78M 70.36M 63.51M 42.49M 39.48M 42.04M 45.64M 46.58M 59.26M 58.69M 58.42M 56.06M 50.83M 45.27M
Interest Expense
6K 11K 12K 13K 14K 13K 12K 9K 5K 2K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -825K -825K 3.74M 3.74M 7.98M 11.58M 7.01M 11.21M 9.36M 5.76M 5.76M 1.56M n/a n/a n/a n/a
Cost & Expenses
69.61M 90.67M 83.53M 98.53M 81.92M 73.46M 66.4M 44.13M 51.56M 54.84M 58.49M 59.41M 61.86M 61.12M 60.7M 58.16M 52.79M 47.43M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 573.42K 573.42K 573.42K 573.42K n/a -0.00 -0.00 -0.00 -0.00 -0.00 n/a n/a
Shares Outstanding (Basic)
21.06M 21M 14.85M 16.95M 16.94M 16.9M 12.82M 11.1M 56.16M 55.42M 42.65M 5.31M 55.2M 55.14M 42.46M 55.09M 55.03M 54.94M
Shares Outstanding (Diluted)
21.06M 21M 14.85M 16.95M 16.94M 16.9M 12.82M 11.1M 56.16M 55.42M 42.65M 5.31M 55.2M 55.14M 42.46M 55.09M 55.03M 54.94M
EPS (Basic)
-4.63 -4.67 -4.59 -4.49 -3.71 -2.83 -2.09 -1.2 -3.15 -3.22 -3.24 -3.28 -1.2 -1.19 -1.18 -1.12 -0.88 -0.81
EPS (Diluted)
-4.63 -4.67 -4.59 -4.49 -3.71 -2.83 -2.09 -1.2 -3.15 -3.22 -3.24 -3.28 -1.2 -1.19 -1.18 -1.12 -0.88 -0.81
EBITDA
-86.08M -77.67M -71.88M -71.44M -56.19M -50.29M -46.41M -40.94M -49M -52.2M -54.67M -56.4M -59.05M -58.67M -58.41M -56.06M -43.01M -37.42M
EBIT
-62.37M -80.86M -75.13M -75.79M -60.1M -54.21M -49.55M -42.83M -51.3M -54.39M -57.48M -59.21M -61.65M -61.09M -60.69M -58.16M -44.97M -39.59M
Depreciation & Amortization
2.37M 3.18M 3.25M 4.34M 3.92M 3.47M 3.26M 2.01M 2.42M 2.77M 2.81M 2.8M 2.6M 2.43M 2.28M 2.1M 1.95M 2.16M